Skip to main content
Lancaster Resources Inc. logo

Lancaster Resources Inc. — Investor Relations & Filings

Ticker · LCR ISIN · CA51440M1023 CSE Mining and quarrying
Open in API
Filings indexed 221 across all filing types
Latest filing 2021-04-30 Regulatory Filings
Country CA Canada
Listing CSE LCR

About Lancaster Resources Inc.

https://lancaster-resources.com/

Lancaster Resources Inc. is a mineral exploration company dedicated to discovering and developing high-potential precious metal and critical mineral assets. The company focuses on gold, lithium, uranium, and polymetallic deposits across established mining jurisdictions, including North America and Australia. Key projects include the Lake Cargelligo Gold Project in New South Wales, Australia, and the Trans-Taiga Lithium Pegmatite Project and Lac Iris Polymetallic Property in Quebec. Lancaster emphasizes advancing projects responsibly with a commitment to sustainable environmental practices and long-term value creation.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate, signed by the CEO certifying the review and fair presentation of the interim financial report and interim MD&A for the period ended February 28, 2021. It is a certification letter rather than the interim report itself, and it explicitly states it is a certificate under National Instrument 52-109. The document length is short (3042 characters) and contains no actual financial data or substantive financial analysis. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report (IR) itself.
2021-04-30 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CFO of NeonMind Biosciences Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended February 28, 2021. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. It references the interim filings but does not include them. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is 3056 characters, which is relatively short and consistent with a certification letter rather than a full report.
2021-04-30 English
Interim MD&A - English.pdf
Regulatory Filings
2021-04-30 English
Interim financial statements/report – English.pdf
Regulatory Filings
2021-04-30 English
Code of conduct.pdf
Regulatory Filings
2021-04-22 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the establishment of a new specialty clinics division by NeonMind Biosciences Inc. and the appointment of a new VP, Corporate Development. It discusses strategic business plans, market context, and personnel changes but does not contain financial statements, regulatory filings, or detailed financial data. There is no indication that this is a formal regulatory filing, earnings release, annual or interim report, or any other specific financial or governance document. It is primarily a corporate announcement about business strategy and management appointment. Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate announcements that do not fit other categories.
2021-04-22 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.